Results 1 - 10 of 93 : 1 2 3 4 5 6 7 8 9 Next
A Top BioMarin Drug Heads Overseas
BioMarin's Kuvan is tentatively given the thumbs up in Europe.
The company presents more data on its molecular diagnostic and buys a lab to run the tests in.
This Just In: Upgrades and Downgrades
Grading the best and the brightest stock raters.
What's better than a high quality stock? A high quality stock that's burning up the charts.
Biotech may combine the benefits of a health care boom with a defensive stock play.
Never underestimate the importance of a moat.
BioMarin's New Drugs Mostly Hit Their Targets
When minor changes in guidance cause increased worries.
Fools like to see growth in sales of high-margin products.
Here's what it takes to make money in the market.
CAPS Screen: 3 Stocks Hitting High Notes
These stocks are bucking the trend.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK